In the clinic for Dec. 8, 2025 Dec. 8, 2025 Clinical updates, including data readouts and publications: Amneal, Amylyx, Biogen, Cantargia, Cervomed, CG, Galimedix, Impact, Oric, Praxis, Rapport, Stoke, Transcenta, Zhittya.Read More
Financings for Dec. 8, 2025 Dec. 8, 2025 Biopharmas raising money in public or private financings, including: Capricor, Immatics, Kala, OTR, Protara.Read More
Appointments and advancements for Dec. 8, 2025 Dec. 8, 2025 New hires and promotions in the biopharma industry, including: Jubilant, K36.Read More
Appointments and advancements for Dec. 8, 2025 Dec. 8, 2025 New hires and promotions in the med-tech industry, including: Bruker, Oxford Nanopore Technologies, Zeiss.Read More
Financings for Dec. 8, 2025 Dec. 8, 2025 Med-tech firms raising money in public or private financings, including: Aethlon Medical.Read More
In the clinic for Dec. 8, 2025 Dec. 8, 2025 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neuropace.Read More
Other news to note for Dec. 8, 2025 Dec. 8, 2025 Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Acon, Asahi Kasei, Eyeyon Medical, Fize Medical, Helio Genomics, Lunit, Olympus, SS Innovations, Staar.Read More
Regulatory actions for Dec. 8, 2025 Dec. 8, 2025 Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Resmed.Read More
Med-tech gainers and losers for Dec. 1-5, 2025 Dec. 8, 2025 The top 10 med-tech stock gainers and losers for the week.Read More
Biggest gainers and losers for Dec. 1-5, 2025 Dec. 8, 2025 The top 10 biopharma stock gainers and losers for the week.Read More